Drugs / tea extracts
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00262145 | Oct → Nov 2005 | diabetes mellitus, obesity disorder | NatureGen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tea extracts | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00262145 ↗ |
| Action | Inhibit | “The in vitro demonstration that tea extracts inhibit pancreatic lipase activity suggests that tea might interfere with triglyceride absorption.” NCT00262145 ↗ |
| Route | Oral | “assigned to drink either 500 ml of the warm active tea preparation” NCT00262145 ↗ |